COMPANY BENEFITS:
Developed the SleepFit app and partnered with Schneider Trucking, leading to nationally recognized follow-on studies to assess fatigue in long-haul truckers.

NASA BENEFITS:
App creation & validation led to significantly reduced testing times.

WE ALL BENEFIT:
SleepFit creates safer roadways by helping drivers assess fatigue.

COMPANY BENEFITS:
Funded development of the programmable sleep mask to first generation commercial device.

NASA BENEFITS:
By shifting the circadian cycle, LumosTech’s smart sleep mask will help ensure that astronauts are at peak performance for a scheduled task.

WE ALL BENEFIT:
Shifting one’s circadian cycle may significantly improve alertness, enhancing safety on the highways, in the skies and in hospitals.

COMPANY BENEFITS:
Enabled Pear to fast-track development of its insomnia product.

NASA BENEFITS:
Pairing of zolpidem and targeted app will help astronauts manage sleep-wake cycles ensuring alertness for mission critical tasks.

WE ALL BENEFIT:
Millions of sleep-deprived people will be able to improve their sleep hygiene.

COMPANY BENEFITS:
Performed groundbreaking studies in mice undergoing proton irradiation.

NASA BENEFITS:
enterade® has the potential to mitigate GI toxicity following radiation exposure.

WE ALL BENEFIT:
enterade® helps alleviate radiation-induced gastroenteritis in oncology patients, allowing for more effective treatment.

COMPANY BENEFITS:
Developed a gel formulation of its MatriStem® product, leading to an issued patent and development of a novel wound healing animal model.

NASA BENEFITS:
Useful to promote healing in the microgravity environment where wounds and abrasions are slow to heal.

WE ALL BENEFIT:
Will help doctors treat deep, irregular wounds.

COMPANY BENEFITS:
Funded refinement of prototypes and early efficacy studies. Validation of the technology helped the company raise a five-fold match of the grant amount.

NASA BENEFITS:
Equinox’s Balance Goggles may prevent ocular changes by normalizing the pressure gradient between intracranial pressure and intraocular pressure.

WE ALL BENEFIT:
Millions of glaucoma patients worldwide may benefit from this alternative therapeutic approach.

COMPANY BENEFITS:
Supported a clinical trial that demonstrated efficacy and the acquisition of another system enabling doctors to evaluate 1,000 soldiers.

NASA BENEFITS:
Monitoring changes in ICP non-invasively will provide valuable information to NASA scientists investigating VIIP

WE ALL BENEFIT:
This device will: 1.) significantly improve diagnosis and tracking of head trauma patients and 2.)remove subjectivity from “return to activity” decisions.

COMPANY BENEFITS:
Supported evaluation of multi-spectral imaging technology to deliver insights on VIIP Syndrome and identified new applications in neurology and neuro-ophthalmology.

NASA BENEFITS:
Earlier detection of retinal anomalies may provide insight into VIIP Syndrome and its impact on visual acuity, eye shape and retinal changes.

WE ALL BENEFIT:
Early detection of retinal changes will enable ophthalmologists to address problems sooner, leading to better outcomes.

COMPANY BENEFITS:
Supported clinical research and the development of key algorithms for the device which served as early stage validation of the company/technology.

NASA BENEFITS:
Offers non-invasive monitoring of changes in intracranial fluids (ICF), expanding our understanding of microgravity’s effects.

WE ALL BENEFIT:
This non-invasive monitor may improve outcomes for acute stroke and TBI patients by enabling early intervention in cases of worsening edema.

COMPANY BENEFITS:
Funded a deep dive into novel approaches in miniaturized vision testing equipment and adjustable power eyeglasses.

NASA BENEFITS:
NASA is now evaluating adjustable power eyeglasses & miniaturized vision testing equipment from companies identified & qualified by Web Vision Centers.

WE ALL BENEFIT:
Adjustable glasses represent a significant improvement over bi/trifocals.

COMPANY BENEFITS:
Supporting development of a lens that can be programmed with far, near and mid-range sections or a single focal length.

NASA BENEFITS:
Electronically adjustable lenses will enable astronauts to adjust their lenses to match the visual demands of the task.

WE ALL BENEFIT:
Accommodating contact lenses, virtual and augmented display optics and dynamic adjustable eyeglasses will enhance visual acuity.

COMPANY BENEFITS:
Funded further development of the device to expand utility and a clinical trial to evaluate efficacy in addressing back pain similar to that experienced by astronauts.

NASA BENEFITS:
Wearable ultrasound device may alleviate back pain/discomfort for astronauts while in space and upon their return to Earth.

WE ALL BENEFIT:
Sam® is used for treatment of muscle injuries and. to help injured workers return to work more quickly.